Business Context and Reporting Period
This Form 8-K is a current report filed by WellPoint, Inc. (now Elevance Health, Inc.) on May 29, 2013, regarding events occurring on May 28, 2013. The filing addresses corporate governance changes, specifically the election of a new director to the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and does not contain financial performance data.
Material Changes
The material change reported is the election of Lewis Hay, III to the WellPoint, Inc. Board of Directors. Key details include:
- Effective Date: July 1, 2013.
- Term: Expires on the date of the Company's 2014 Annual Meeting of Shareholders.
- Committee Assignments: Mr. Hay was appointed to the Audit, Compensation, and Strategic Innovation Committees.
- Compensation: Mr. Hay will participate in the standard director compensation program described in the proxy statement filed on April 2, 2013.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on financial performance, or discussion of risks and contingencies. The document confirms there are no undisclosed arrangements or relationships between Mr. Hay and the Company requiring disclosure under Item 404(a) of Regulation S-K.
Key Facts for Investor Verification
- Verify the effective date of Lewis Hay, III's board membership (July 1, 2013).
- Confirm Mr. Hay's specific committee assignments (Audit, Compensation, Strategic Innovation).
- Review the Company's proxy statement filed on April 2, 2013, for details on the director compensation program applicable to Mr. Hay.
- Note that this filing relates to WellPoint, Inc., the predecessor name to Elevance Health, Inc.